Wang Jinle, Jiang Huihui, Bi Qingqing, Tian Kegang, Mu Xiaofeng, Zhang Lei
Department of Clinical Laboratory, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, China.
J Int Med Res. 2025 Aug;53(8):3000605251363520. doi: 10.1177/03000605251363520. Epub 2025 Aug 5.
Arterial catheter blood sampling is widely used among critically ill patients to minimize repeated punctures; however, improper techniques may lead to misleading laboratory results. This case report presents a clinically significant hemoglobin discrepancy observed between blood gas analyzer and automated hematology analyzer during arterial catheter sampling in a patient with cerebral infarction. After catheter placement, the interplatform hemoglobin discrepancy reached 13 g/L despite prior concordance. The discordance was attributed to pre-analytical errors, including inadequate discard volume (4-5 mL) of heparinized saline-contaminated blood, which causes sample dilution. This case underscores that catheter sampling protocols must rigorously focus on dead space clearance to prevent artifactual hemoglobin variations. Such vigilance is particularly critical in hemodynamically unstable patients, in whom erroneous values may directly impact transfusion decisions. Adherence to evidence-based discard volume guidelines, with protocol tailoring based on individual patient factors, constitutes an essential safeguard for test accuracy in critical care settings.
动脉导管采血在重症患者中被广泛应用,以尽量减少反复穿刺;然而,操作不当可能导致实验室结果出现误导。本病例报告介绍了一名脑梗死患者在动脉导管采样过程中,血气分析仪和自动血液学分析仪之间观察到临床上显著的血红蛋白差异。导管置入后,尽管之前结果一致,但不同检测平台间的血红蛋白差异仍达13 g/L。这种不一致归因于分析前误差,包括肝素盐水污染血液的弃血体积不足(4 - 5 mL),这会导致样本稀释。该病例强调,导管采样方案必须严格关注死腔清除,以防止血红蛋白出现人为变化。这种警惕在血流动力学不稳定的患者中尤为关键,因为错误的值可能直接影响输血决策。遵循基于证据的弃血体积指南,并根据个体患者因素调整方案,是重症监护环境中检测准确性的重要保障。